# Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors

> **NCT07095517** · PHASE1 · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Colorectal Cancer Prevention
- Colorectal Adenoma

## Interventions

- **DRUG:** Tirzepatide

## Key facts

- **NCT ID:** NCT07095517
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-24
- **Primary completion:** 2027-03-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07095517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07095517, "Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07095517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*